Authors

• Jarno Satopää (ORCID: https://orcid.org/0000-0002-2674-0301)
• Paula Tiili (ORCID: https://orcid.org/0000-0002-7916-7262)
• Janne Kinnunen (ORCID: https://orcid.org/0000-0002-0592-3184)
• Mika Niemelä (ORCID: https://orcid.org/0000-0003-1526-0684)
• Juhani Airaksinen (ORCID: https://orcid.org/0000-0002-0193-568X)
• Juha E.K. Hartikainen (ORCID: https://orcid.org/0000-0003-0847-107X)
• Aapo L. Aro (ORCID: https://orcid.org/0000-0001-7030-6740)
• Olli Halminen (ORCID: https://orcid.org/0000-0001-9266-8435)
• Jukka Putaala A (ORCID: https://orcid.org/0000-0002-6630-6104)
• Miikka Korja (ORCID: https://orcid.org/0000-0002-4463-6954)
• Jari K. Haukka (ORCID: https://orcid.org/0000-0003-1450-6208)
• Mika Lehto (ORCID: https://orcid.org/0000-0002-8691-5142)
• Ossi Lehtonen (ORCID: https://orcid.org/0009-0009-4914-1027)
• Miika Linna (ORCID: https://orcid.org/0000-0003-2237-6933)
• P Mustonen (ORCID: https://orcid.org/0009-0004-1472-0946)

Institutions

• University of Helsinki (FI)
• University of Turku (FI)
• University of Eastern Finland (FI)
• Helsinki University Hospital (FI)
• Jorvi Hospital (FI)
• Turku University Hospital (FI)
• Kuopio University Hospital (FI)
• Finland University (FI)
• Hospital District of Helsinki and Uusimaa (FI)
• Aalto University (FI)

Publication Details

Journal

Journal of the American Heart Association

Published

2025-06-11

DOI

https://doi.org/10.1161/jaha.124.040360

Primary Topic

Atrial Fibrillation Management and Outcomes

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Amgen
• Pfizer
• Foundation for Cardiovascular Research
• Wilhelm och Else Stockmanns Stiftelse
• Aarne Koskelon Säätiö
• Novo Nordisk
• Sydäntutkimussäätiö
• Aarne ja Aili Turusen Säätiö